These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17227932)

  • 21. Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study.
    Rasmussen LD; May MT; Kronborg G; Larsen CS; Pedersen C; Gerstoft J; Obel N
    Lancet HIV; 2015 Jul; 2(7):e288-98. PubMed ID: 26423253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study.
    Obel N; Omland LH; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Sørensen HT; Gerstoft J
    PLoS One; 2011; 6(7):e22698. PubMed ID: 21799935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population.
    Jensen-Fangel S; Pedersen L; Pedersen C; Larsen CS; Tauris P; Møller A; Sørensen HT; Obel N
    AIDS; 2004 Jan; 18(1):89-97. PubMed ID: 15090834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy.
    Fang CT; Chang YY; Hsu HM; Twu SJ; Chen KT; Lin CC; Huang LY; Chen MY; Hwang JS; Wang JD; Chuang CY
    QJM; 2007 Feb; 100(2):97-105. PubMed ID: 17277317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
    PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
    Helleberg M; May MT; Ingle SM; Dabis F; Reiss P; Fätkenheuer G; Costagliola D; d'Arminio A; Cavassini M; Smith C; Justice AC; Gill J; Sterne JA; Obel N
    AIDS; 2015 Jan; 29(2):221-9. PubMed ID: 25426809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
    Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
    JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).
    Klein MB; Rollet-Kurhajec KC; Moodie EE; Yaphe S; Tyndall M; Walmsley S; Gill J; Martel-Laferriere V; Cooper C;
    AIDS; 2014 Aug; 28(13):1957-65. PubMed ID: 25259703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden.
    de Coninck Z; Hussain-Alkhateeb L; Bratt G; Ekström AM; Gisslén M; Petzold M; Svedhem V
    AIDS Patient Care STDS; 2018 Aug; 32(8):297-305. PubMed ID: 30067408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
    Qurishi N; Kreuzberg C; Lüchters G; Effenberger W; Kupfer B; Sauerbruch T; Rockstroh JK; Spengler U
    Lancet; 2003 Nov; 362(9397):1708-13. PubMed ID: 14643119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.
    Crum NF; Riffenburgh RH; Wegner S; Agan BK; Tasker SA; Spooner KM; Armstrong AW; Fraser S; Wallace MR;
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):194-200. PubMed ID: 16394852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the risk of death after HIV seroconversion compared with mortality in the general population.
    Bhaskaran K; Hamouda O; Sannes M; Boufassa F; Johnson AM; Lambert PC; Porter K;
    JAMA; 2008 Jul; 300(1):51-9. PubMed ID: 18594040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.
    Hansen AB; Lohse N; Gerstoft J; Kronborg G; Laursen A; Pedersen C; Sørensen HT; Obel N
    PLoS One; 2007 Aug; 2(8):e738. PubMed ID: 17710138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012.
    Eyawo O; Franco-Villalobos C; Hull MW; Nohpal A; Samji H; Sereda P; Lima VD; Shoveller J; Moore D; Montaner JS; Hogg RS;
    BMC Infect Dis; 2017 Feb; 17(1):174. PubMed ID: 28241797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark.
    Helleberg M; Pedersen MG; Pedersen CB; Mortensen PB; Obel N
    Lancet HIV; 2015 Aug; 2(8):e344-50. PubMed ID: 26423377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.
    Palella FJ; Armon C; Buchacz K; Cole SR; Chmiel JS; Novak RM; Wood K; Moorman AC; Brooks JT;
    Ann Intern Med; 2009 Jul; 151(2):73-84. PubMed ID: 19620160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
    Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study.
    Rasmussen LD; Kronborg G; Larsen CS; Pedersen C; Gerstoft J; Obel N; Pottegård A
    Infect Dis (Lond); 2017 Jan; 49(1):42-54. PubMed ID: 27686116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.